Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1(1-13C) Sodium Acetate[2] Acetate (Acetate ion),
Sodium acetate (Sodium acetate trihydrate)
[1] Sodium acetate (Sodium acetate, Sodium acetate hydrate, Sodium acetate trihydrate) 💬 --[1] 251 💬
211C-acetate[1] Acetate (Acetate ion)---[2] 86, 88 💬
32% Chlorhexidine solution wipes
(Chlorhexidine acetate)
[1] Chlorhexidine (Chlorhexidine acetate)[4] Chlorhexidine gluconate ,
Chlorhexidine hydrochloride ,
Chlorhexidine ,
Chlorhexidine acetate (Chlorhexidine acetate) 💬
--[1] 299 💬
42-HOBA acetate (2-Hydroxybenzlamine acetate)[1] Acetate (Acetate ion)---[1] 49 💬
520mg/0.5ml glatiramer acetate[2] Acetate (Acetate ion),
Glatiramer (Glatiramer acetate)
[1] Glatiramer acetate (Glatiramer acetate) 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬
[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
64% chlorhexidine gluconate liquid skin cleanser
(Chlorhexidine acetate)
[1] Chlorhexidine (Chlorhexidine acetate)[4] Chlorhexidine gluconate ,
Chlorhexidine hydrochloride ,
Chlorhexidine ,
Chlorhexidine acetate (Chlorhexidine acetate) 💬
--[1] 299 💬
740 mg glatiramer acetate[2] Acetate (Acetate ion),
Glatiramer (Glatiramer acetate)
[1] Glatiramer acetate (Glatiramer acetate) 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬
[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[2] 2, 13 💬
840 mg Glatiramer acetato
(Glatiramer acetate)
[1] Glatiramer (Glatiramer acetate)[1] Glatiramer acetate (Glatiramer acetate) 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬
[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
990 mg hydrocortisone acetate suppository with Sephure suppository applicator[3] Acetate (Acetate ion),
Hydrocortisone,
Hydrocortisone acetate (Hydrocortisone 21-acetate)
[2] Hydrocortisone ,
Hydrocortisone acetate (Hydrocortisone acetate, HYDROCORTISONE ACETATE CREAM) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
10[11C]acetate[1] Acetate (Acetate ion)---[2] 89, 158 💬
11[N-trans-3-Hexenoyl] Human Growth Hormone Releasing Factor (1-44) Acetate[1] Acetate (Acetate ion)---[1] 265 💬
12[OCTREOTIDE ACETATO]
(Octreotide acetate)
[1] Octreotide (Octreotide acetate)[5] Octreotide ,
Octreotide acetate (Octreotide acetate),
Octreotide pamoate ,
Octreotide acetate (Octreotide acetate),
Octreotide hydrochloride 💬
[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 227 💬
13Abiraterone
(Abiraterone acetate)
[1] Abiraterone (Abiraterone acetate)[1] Abiraterone acetate (Abiraterone acetate) 💬 [1] CYP17A1 💬 [5] Cortisol synthesis and secretion, Cushing syndrome, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis 💬[2] 75, 81 💬
14Abiraterone Acetate[2] Abiraterone (Abiraterone acetate),
Acetate (Acetate ion)
[1] Abiraterone acetate (Abiraterone acetate) 💬 [1] CYP17A1 💬 [5] Cortisol synthesis and secretion, Cushing syndrome, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis 💬[2] 75, 81 💬
15Abiraterone acetato
(Abiraterone acetate)
[1] Abiraterone (Abiraterone acetate)[1] Abiraterone acetate (Abiraterone acetate) 💬 [1] CYP17A1 💬 [5] Cortisol synthesis and secretion, Cushing syndrome, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis 💬[1] 75 💬
16Acetate[1] Acetate (Acetate ion)---[52] 1, 2, 6, 10, 11, 13, 22, 35, 40, 46, 49, 51, 60, 63, 64, 65, 66, 67, 70, 71, 73, 75, 76, 77, 78, 79, 81, 83, 85, 86, 88, 89, 90, 96, 97, 113, 145, 156, 158, 162, 171, 206, 222, 223, 224, 225, 227, 235, 251, 265, 298, 299 💬
17Administration of Methylprednisolone + Prednisone + Mycophenolate mofetil
(Methylprednisolone acetate)
[3] Methylprednisolone (Methylprednisolone acetate),
Mycophenolate mofetil,
Prednisone
[5] Methylprednisolone ,
Prednisone ,
Mycophenolate mofetil ,
Methylprednisolone acetate (Methylprednisolone acetate),
Mycophenolate mofetil hydrochloride 💬
[3] IMPDH1,
IMPDH2,
NR3C1 💬
[3] Drug metabolism - other enzymes, Neuroactive ligand-receptor interaction, Purine metabolism 💬[1] 49 💬
18Administration of methylprednisolone, paracetamol and dexchlorpheniramine
(Methylprednisolone acetate)
[2] Dexchlorpheniramine,
Methylprednisolone (Methylprednisolone acetate)
[3] Methylprednisolone ,
Methylprednisolone acetate (Methylprednisolone acetate),
Dexchlorpheniramine 💬
[2] HRH1,
NR3C1 💬
[4] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[1] 49 💬
19Administration of rituximab and methylprednisolone
(Methylprednisolone acetate)
[2] Methylprednisolone (Methylprednisolone acetate),
Rituximab
[3] Methylprednisolone ,
Methylprednisolone acetate (Methylprednisolone acetate),
Rituximab 💬
[2] MS4A1,
NR3C1 💬
[2] Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬[1] 51 💬
20AFAMELANOTIDE
(Afamelanotide acetate)
[1] Afamelanotide (Afamelanotide acetate)[2] Afamelanotide ,
Afamelanotide acetate (Afamelanotide acetate) 💬
[1] MC1R 💬 [3] Hormone signaling, Melanogenesis, Neuroactive ligand-receptor interaction 💬[2] 159, 254 💬
21Afamelanotide (16 mg implant)
(Afamelanotide acetate)
[1] Afamelanotide (Afamelanotide acetate)[2] Afamelanotide ,
Afamelanotide acetate (Afamelanotide acetate) 💬
[1] MC1R 💬 [3] Hormone signaling, Melanogenesis, Neuroactive ligand-receptor interaction 💬[1] 159 💬
22Afamelanotide 16 MG
(Afamelanotide acetate)
[1] Afamelanotide (Afamelanotide acetate)[2] Afamelanotide ,
Afamelanotide acetate (Afamelanotide acetate) 💬
[1] MC1R 💬 [3] Hormone signaling, Melanogenesis, Neuroactive ligand-receptor interaction 💬[1] 254 💬
23Afamelanotide 16mg implant
(Afamelanotide acetate)
[1] Afamelanotide (Afamelanotide acetate)[2] Afamelanotide ,
Afamelanotide acetate (Afamelanotide acetate) 💬
[1] MC1R 💬 [3] Hormone signaling, Melanogenesis, Neuroactive ligand-receptor interaction 💬[1] 254 💬
24Afamelanotide Implant
(Afamelanotide acetate)
[1] Afamelanotide (Afamelanotide acetate)[2] Afamelanotide ,
Afamelanotide acetate (Afamelanotide acetate) 💬
[1] MC1R 💬 [3] Hormone signaling, Melanogenesis, Neuroactive ligand-receptor interaction 💬[1] 254 💬
25Angiotensin II
(Angiotensin II acetate)
[1] Angiotensin II (Angiotensin II acetate)[3] Angiotensin II ,
Angiotensin II ,
Angiotensin II acetate (Angiotensin II acetate) 💬
[2] AGTR1,
AGTR2 💬
[17] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[2] 66, 222 💬
26Atosiban
(Atosiban acetate)
[1] Atosiban (Atosiban acetate)[2] Atosiban ,
Atosiban acetate (Atosiban acetate) 💬
[1] OXTR 💬 [5] Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬[1] 118 💬
27AZTREONAM LYSINE
(Lysine acetate, L-Lysine acetate)
[2] Aztreonam,
Lysine (Lysine acetate)
[6] Aztreonam ,
Lysine acetate (Lysine acetate, L-Lysine acetate),
Lysine hydrochloride ,
Lysine ,
Lysine hydrochloride ,
Aztreonam lysine 💬
--[1] 299 💬
28Aztreonam Lysine for Inhalation
(Lysine acetate, L-Lysine acetate)
[2] Aztreonam,
Lysine (Lysine acetate)
[6] Aztreonam ,
Lysine acetate (Lysine acetate, L-Lysine acetate),
Lysine hydrochloride ,
Lysine ,
Lysine hydrochloride ,
Aztreonam lysine 💬
--[1] 299 💬
29Aztreonam Lysine for Inhalation (AZLI)
(Lysine acetate, L-Lysine acetate)
[2] Aztreonam,
Lysine (Lysine acetate)
[6] Aztreonam ,
Lysine acetate (Lysine acetate, L-Lysine acetate),
Lysine hydrochloride ,
Lysine ,
Lysine hydrochloride ,
Aztreonam lysine 💬
--[1] 228 💬
30Aztreonan lysine
(Lysine acetate, L-Lysine acetate)
[1] Lysine (Lysine acetate)[4] Lysine acetate (Lysine acetate, L-Lysine acetate),
Lysine hydrochloride ,
Lysine ,
Lysine hydrochloride 💬
--[1] 299 💬
31Basic treatment: sulperazone + ursodeoxycholic acid + compound glycyrrhizin + methylprednisolone + vitamin AD , D , E , K + imipenem or meropenem
(Methylprednisolone acetate)
[4] Imipenem,
Meropenem,
Methylprednisolone (Methylprednisolone acetate),
Ursodeoxycholic acid
[7] Imipenem ,
Methylprednisolone ,
Ursodiol ,
Methylprednisolone acetate (Methylprednisolone acetate),
Meropenem ,
Imipenem ,
Meropenem 💬
[2] NR1H4,
NR3C1 💬
[2] Bile secretion, Neuroactive ligand-receptor interaction 💬[1] 296 💬
32Bazedoxifene
(Bazedoxifene acetate)
[1] Bazedoxifene (Bazedoxifene acetate)[1] Bazedoxifene acetate (Bazedoxifene acetate) 💬 [2] ESR1,
ESR2 💬
[10] Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬[1] 13 💬
33Bazedoxifene Acetate[2] Acetate (Acetate ion),
Bazedoxifene (Bazedoxifene acetate)
[1] Bazedoxifene acetate (Bazedoxifene acetate) 💬 [2] ESR1,
ESR2 💬
[10] Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬[1] 13 💬
34Betamethasone
(Betamethasone acetate)
[1] Betamethasone (Betamethasone acetate)[6] Betamethasone ,
Betamethasone sodium phosphate ,
Betamethasone valerate ,
Betamethasone acetate (Betamethasone acetate),
Betamethasone dipropionate ,
Betamethasone benzoate 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[9] 2, 28, 46, 56, 65, 83, 90, 96, 235 💬
35BETAMETHASONE ACIBUTATE
(Betamethasone acetate)
[1] Betamethasone (Betamethasone acetate)[6] Betamethasone ,
Betamethasone sodium phosphate ,
Betamethasone valerate ,
Betamethasone acetate (Betamethasone acetate),
Betamethasone dipropionate ,
Betamethasone benzoate 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
36Betamethasone mouthwash
(Betamethasone acetate)
[1] Betamethasone (Betamethasone acetate)[6] Betamethasone ,
Betamethasone sodium phosphate ,
Betamethasone valerate ,
Betamethasone acetate (Betamethasone acetate),
Betamethasone dipropionate ,
Betamethasone benzoate 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 56 💬
37Betamethasone Oral Solution Period 1 and Period 2
(Betamethasone acetate)
[1] Betamethasone (Betamethasone acetate)[6] Betamethasone ,
Betamethasone sodium phosphate ,
Betamethasone valerate ,
Betamethasone acetate (Betamethasone acetate),
Betamethasone dipropionate ,
Betamethasone benzoate 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 65 💬
38Betamethasone sodium phosphate/betamethasone acetate (Celestone® Soluspan®), 30 mg IM once a day for four days[2] Acetate (Acetate ion),
Betamethasone (Betamethasone acetate)
[6] Betamethasone ,
Betamethasone sodium phosphate ,
Betamethasone valerate ,
Betamethasone acetate (Betamethasone acetate),
Betamethasone dipropionate ,
Betamethasone benzoate 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 2 💬
39Betamethasone solution as intramuscular injection Period 1 and Period 2
(Betamethasone acetate)
[1] Betamethasone (Betamethasone acetate)[6] Betamethasone ,
Betamethasone sodium phosphate ,
Betamethasone valerate ,
Betamethasone acetate (Betamethasone acetate),
Betamethasone dipropionate ,
Betamethasone benzoate 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 65 💬
40CAM2029 (Octreotide subcutaneous depot)
(Octreotide acetate)
[1] Octreotide (Octreotide acetate)[5] Octreotide ,
Octreotide acetate (Octreotide acetate),
Octreotide pamoate ,
Octreotide acetate (Octreotide acetate),
Octreotide hydrochloride 💬
[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
41CAM2029 (Octreotide subcutaneous depot) _prefilled syringe_prefilled syringe
(Octreotide acetate)
[1] Octreotide (Octreotide acetate)[5] Octreotide ,
Octreotide acetate (Octreotide acetate),
Octreotide pamoate ,
Octreotide acetate (Octreotide acetate),
Octreotide hydrochloride 💬
[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
42CAM2029 (Octreotide subcutaneous depot)_ prefilled pen
(Octreotide acetate)
[1] Octreotide (Octreotide acetate)[5] Octreotide ,
Octreotide acetate (Octreotide acetate),
Octreotide pamoate ,
Octreotide acetate (Octreotide acetate),
Octreotide hydrochloride 💬
[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
43CAM2029 (Octreotide subcutaneous depot)_ prefilled syringe
(Octreotide acetate)
[1] Octreotide (Octreotide acetate)[5] Octreotide ,
Octreotide acetate (Octreotide acetate),
Octreotide pamoate ,
Octreotide acetate (Octreotide acetate),
Octreotide hydrochloride 💬
[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
44CAM2029 (Octreotide subcutaneous depot)_pre-filled pen
(Octreotide acetate)
[1] Octreotide (Octreotide acetate)[5] Octreotide ,
Octreotide acetate (Octreotide acetate),
Octreotide pamoate ,
Octreotide acetate (Octreotide acetate),
Octreotide hydrochloride 💬
[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
45CAM2029 (Octreotide subcutaneous depot)_pre-filled syringe
(Octreotide acetate)
[1] Octreotide (Octreotide acetate)[5] Octreotide ,
Octreotide acetate (Octreotide acetate),
Octreotide pamoate ,
Octreotide acetate (Octreotide acetate),
Octreotide hydrochloride 💬
[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
46CAM2029 (Octreotide subcutaneous depot)_prefilled pen
(Octreotide acetate)
[1] Octreotide (Octreotide acetate)[5] Octreotide ,
Octreotide acetate (Octreotide acetate),
Octreotide pamoate ,
Octreotide acetate (Octreotide acetate),
Octreotide hydrochloride 💬
[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
47CAM2029 (Octreotide subcutaneous depot)_prefilled syringe
(Octreotide acetate)
[1] Octreotide (Octreotide acetate)[5] Octreotide ,
Octreotide acetate (Octreotide acetate),
Octreotide pamoate ,
Octreotide acetate (Octreotide acetate),
Octreotide hydrochloride 💬
[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
48Caspofungin
(Caspofungin acetate)
[1] Caspofungin (Caspofungin acetate)[2] Caspofungin acetate (Caspofungin acetate),
Caspofungin 💬
--[1] 60 💬
49CASPOFUNGIN ACETATE[2] Acetate (Acetate ion),
Caspofungin (Caspofungin acetate)
[2] Caspofungin acetate (Caspofungin acetate),
Caspofungin 💬
--[1] 60 💬
50Cellulose acetate with petrolatum[2] Acetate (Acetate ion),
Petrolatum
[2] Petrolatum, white ,
Petrolatum 💬
--[2] 35, 162 💬
51Cetrorelix
(Cetrorelix acetate)
[1] Cetrorelix (Cetrorelix acetate)[2] Cetrorelix acetate (Cetrorelix acetate),
Cetrorelix 💬
[1] GNRHR 💬 [3] GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬[1] 46 💬
52Chlorhexidine
(Chlorhexidine acetate)
[1] Chlorhexidine (Chlorhexidine acetate)[4] Chlorhexidine gluconate ,
Chlorhexidine hydrochloride ,
Chlorhexidine ,
Chlorhexidine acetate (Chlorhexidine acetate) 💬
--[2] 86, 299 💬
53Chlorhexidine Gluconate
(Chlorhexidine acetate)
[1] Chlorhexidine (Chlorhexidine acetate)[4] Chlorhexidine gluconate ,
Chlorhexidine hydrochloride ,
Chlorhexidine ,
Chlorhexidine acetate (Chlorhexidine acetate) 💬
--[1] 299 💬
54Chlorhexidine gluconate oral rinse
(Chlorhexidine acetate)
[1] Chlorhexidine (Chlorhexidine acetate)[4] Chlorhexidine gluconate ,
Chlorhexidine hydrochloride ,
Chlorhexidine ,
Chlorhexidine acetate (Chlorhexidine acetate) 💬
--[1] 299 💬
55Combination Product: Twice daily 90 mg hydrocortisone acetate suppository administered with Sephure applicator[3] Acetate (Acetate ion),
Hydrocortisone,
Hydrocortisone acetate (Hydrocortisone 21-acetate)
[2] Hydrocortisone ,
Hydrocortisone acetate (Hydrocortisone acetate, HYDROCORTISONE ACETATE CREAM) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
56Combination with somatostatin analogue octreotide
(Octreotide acetate)
[2] Octreotide (Octreotide acetate),
Somatostatin (Somatostatin acetate)
[6] Octreotide ,
Octreotide acetate (Octreotide acetate),
Octreotide pamoate ,
Octreotide acetate (Octreotide acetate),
Somatostatin ,
Octreotide hydrochloride 💬
[5] SSTR1,
SSTR2,
SSTR3,
SSTR4,
SSTR5 💬
[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
57Conventional Glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone)[7] Acetate (Acetate ion),
Cortisone,
Cortisone acetate (Cortone acetate),
Dexamethasone,
Hydrocortisone,
Prednisolone,
Prednisone
[8] Hydrocortisone ,
Dexamethasone ,
Prednisolone ,
Prednisone ,
Cortisone acetate (Cortisone acetate, Cortone acetate),
Dexamethasone sodium phosphate ,
Cortisone ,
Dexamethasone phosphate 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 81 💬
58Corticosteroid treatment (Methylprednisolone or prednisolone)
(Methylprednisolone acetate)
[2] Methylprednisolone (Methylprednisolone acetate),
Prednisolone
[3] Methylprednisolone ,
Prednisolone ,
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 64 💬
59Cortisone acetate[3] Acetate (Acetate ion),
Cortisone,
Cortisone acetate (Cortone acetate)
[2] Cortisone acetate (Cortisone acetate, Cortone acetate),
Cortisone 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 81 💬
60Cosyntropin acetate[2] Acetate (Acetate ion),
Tetracosactide (Tetracosactide acetate)
[2] Cosyntropin ,
Tetracosactide acetate (Tetracosactide acetate) 💬
[1] MC2R 💬 [6] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 113 💬
61Cyclophosphamide, Azathioprine,prednisone,methylprednisolone
(Methylprednisolone acetate)
[4] Azathioprine,
Cyclophosphamide,
Methylprednisolone (Methylprednisolone acetate),
Prednisone
[7] Azathioprine ,
Cyclophosphamide ,
Methylprednisolone ,
Prednisone ,
Methylprednisolone acetate (Methylprednisolone acetate),
Azathioprine sodium ,
Cyclophosphamide 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[3] 42, 43, 45 💬
62Cyclophosphamide/Glatiramer acetate[3] Acetate (Acetate ion),
Cyclophosphamide,
Glatiramer (Glatiramer acetate)
[3] Cyclophosphamide ,
Glatiramer acetate (Glatiramer acetate),
Cyclophosphamide 💬
[20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬
[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
63Delmitide acetate[2] Acetate (Acetate ion),
Delmitide
---[1] 97 💬
64Depot leuprolide acetate 3.75 mg[2] Acetate (Acetate ion),
Leuprolide (Leuprolide acetate)
[3] Leuprolide acetate (Leuprolide acetate, Leuprorelin acetate, LEUPROLIDE ACETATE DEPOT),
Leuprolide ,
Leuprolide mesylate 💬
[1] GNRHR 💬 [3] GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬[1] 51 💬
65Depot tetracosactide
(Tetracosactide acetate)
[1] Tetracosactide (Tetracosactide acetate)[2] Cosyntropin ,
Tetracosactide acetate (Tetracosactide acetate) 💬
[1] MC2R 💬 [6] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 83 💬
66Desmopressin
(Desmopressin acetate, Desmopressin acetate hydrate, Desmopressin acetate trihydrate)
[1] Desmopressin (Desmopressin acetate anhydrous)[2] Desmopressin ,
Desmopressin acetate (Desmopressin acetate, Desmopressin acetate hydrate, Desmopressin acetate trihydrate) 💬
[2] AVPR2,
F8 💬
[5] Complement and coagulation cascades, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[8] 6, 22, 64, 72, 75, 223, 225, 288 💬
67Desmopressin Acetat
(Desmopressin acetate, Desmopressin acetate hydrate, Desmopressin acetate trihydrate)
[1] Desmopressin (Desmopressin acetate anhydrous)[2] Desmopressin ,
Desmopressin acetate (Desmopressin acetate, Desmopressin acetate hydrate, Desmopressin acetate trihydrate) 💬
[2] AVPR2,
F8 💬
[5] Complement and coagulation cascades, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[1] 6 💬
68Desmopressin acetate[2] Acetate (Acetate ion),
Desmopressin (Desmopressin acetate anhydrous)
[2] Desmopressin ,
Desmopressin acetate (Desmopressin acetate, Desmopressin acetate hydrate, Desmopressin acetate trihydrate) 💬
[2] AVPR2,
F8 💬
[5] Complement and coagulation cascades, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[2] 64, 75 💬
69DESMOPRESSIN ACETATE TRIHYDRATE[2] Acetate (Acetate ion),
Desmopressin (Desmopressin acetate anhydrous)
[2] Desmopressin ,
Desmopressin acetate (Desmopressin acetate, Desmopressin acetate hydrate, Desmopressin acetate trihydrate) 💬
[2] AVPR2,
F8 💬
[5] Complement and coagulation cascades, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[1] 225 💬
70Desmopressin intranasal
(Desmopressin acetate, Desmopressin acetate hydrate, Desmopressin acetate trihydrate)
[1] Desmopressin (Desmopressin acetate anhydrous)[2] Desmopressin ,
Desmopressin acetate (Desmopressin acetate, Desmopressin acetate hydrate, Desmopressin acetate trihydrate) 💬
[2] AVPR2,
F8 💬
[5] Complement and coagulation cascades, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[1] 72 💬
71Desmopressin Oral Melt
(Desmopressin acetate, Desmopressin acetate hydrate, Desmopressin acetate trihydrate)
[1] Desmopressin (Desmopressin acetate anhydrous)[2] Desmopressin ,
Desmopressin acetate (Desmopressin acetate, Desmopressin acetate hydrate, Desmopressin acetate trihydrate) 💬
[2] AVPR2,
F8 💬
[5] Complement and coagulation cascades, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[1] 72 💬
72DEXAMETHASONE ACETATE[3] Acetate (Acetate ion),
Dexamethasone,
Dexamethasone acetate (Dexamethasone acetate anhydrous)
[5] Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone acetate (Dexamethasone acetate),
Dexamethasone 21-acetate (Dexamethasone 21-acetate, Dexamethasone acetate anhydrous),
Dexamethasone phosphate 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 63 💬
73Diagnostic Test: Gonadorelin acetate and Triptorelin acetate[3] Acetate (Acetate ion),
Gonadorelin (Gonadorelin acetate),
Triptorelin (Triptorelin acetate)
[6] Gonadorelin hydrochloride ,
Gonadorelin acetate (Gonadorelin acetate),
Triptorelin ,
Triptorelin pamoate ,
Gonadorelin ,
Triptorelin acetate (Triptorelin acetate) 💬
[1] GNRHR 💬 [3] GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬[1] 76 💬
74Diagnostic Test: Triptorelin acetate and Gonadorelin acetate[3] Acetate (Acetate ion),
Gonadorelin (Gonadorelin acetate),
Triptorelin (Triptorelin acetate)
[6] Gonadorelin hydrochloride ,
Gonadorelin acetate (Gonadorelin acetate),
Triptorelin ,
Triptorelin pamoate ,
Gonadorelin ,
Triptorelin acetate (Triptorelin acetate) 💬
[1] GNRHR 💬 [3] GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬[1] 76 💬
75Dirucotide acetate[2] Acetate (Acetate ion),
Dirucotide
[1] Dirucotide 💬 --[1] 13 💬
76Edratide Acetate[2] Acetate (Acetate ion),
Edratide
[1] Edratide 💬 --[1] 49 💬
77Experimental Glatiramer Acetate[2] Acetate (Acetate ion),
Glatiramer (Glatiramer acetate)
[1] Glatiramer acetate (Glatiramer acetate) 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬
[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
78Firazyr (icatibant) 30 mg solution for injection in pre filled syringe
(Icatibant acetate)
[1] Icatibant (Icatibant acetate)[1] Icatibant acetate (Icatibant acetate) 💬 [1] BDKRB2 💬 [10] Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 65 💬
79Flecainide
(Flecainide acetate)
[1] Flecainide (Flecainide acetate)[2] Flecainide acetate (Flecainide acetate),
Flecainide 💬
[6] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬
[5] Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬[2] 6, 115 💬
80Flecainide + beta-blocker
(Flecainide acetate)
[1] Flecainide (Flecainide acetate)[2] Flecainide acetate (Flecainide acetate),
Flecainide 💬
[6] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬
[5] Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬[1] 115 💬
81FLECAINIDE ACETATE[2] Acetate (Acetate ion),
Flecainide (Flecainide acetate)
[2] Flecainide acetate (Flecainide acetate),
Flecainide 💬
[6] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬
[5] Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬[1] 6 💬
82Fludrocortisone
(Fludrocortisone acetate, Florinef acetate)
[1] Fludrocortisone (Fludrocortisone acetate)[2] Fludrocortisone acetate (Fludrocortisone acetate, Florinef acetate),
Fludrocortisone 💬
[1] NR3C2 💬 [1] Aldosterone-regulated sodium reabsorption 💬[3] 6, 17, 81 💬
83Gallium-68-DOTA-N-Octreotide
(Octreotide acetate)
[1] Octreotide (Octreotide acetate)[5] Octreotide ,
Octreotide acetate (Octreotide acetate),
Octreotide pamoate ,
Octreotide acetate (Octreotide acetate),
Octreotide hydrochloride 💬
[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 84 💬
84Glatiramer
(Glatiramer acetate)
[1] Glatiramer (Glatiramer acetate)[1] Glatiramer acetate (Glatiramer acetate) 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬
[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[4] 2, 13, 96, 156 💬
85GLATIRAMER ACETATE[2] Acetate (Acetate ion),
Glatiramer (Glatiramer acetate)
[1] Glatiramer acetate (Glatiramer acetate) 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬
[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[3] 13, 96, 156 💬
86Glatiramer Acetate (Copaxone®)[2] Acetate (Acetate ion),
Glatiramer (Glatiramer acetate)
[1] Glatiramer acetate (Glatiramer acetate) 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬
[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[2] 13, 156 💬
87Glatiramer Acetate (DB)[2] Acetate (Acetate ion),
Glatiramer (Glatiramer acetate)
[1] Glatiramer acetate (Glatiramer acetate) 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬
[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
88Glatiramer Acetate (GA)[2] Acetate (Acetate ion),
Glatiramer (Glatiramer acetate)
[1] Glatiramer acetate (Glatiramer acetate) 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬
[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
89Glatiramer Acetate (GA) 40 mg[2] Acetate (Acetate ion),
Glatiramer (Glatiramer acetate)
[1] Glatiramer acetate (Glatiramer acetate) 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬
[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
90Glatiramer Acetate (GTR)[2] Acetate (Acetate ion),
Glatiramer (Glatiramer acetate)
[1] Glatiramer acetate (Glatiramer acetate) 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬
[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
91Glatiramer Acetate (OL)[2] Acetate (Acetate ion),
Glatiramer (Glatiramer acetate)
[1] Glatiramer acetate (Glatiramer acetate) 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬
[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
92Glatiramer acetate 150mg enteric coated tablets[2] Acetate (Acetate ion),
Glatiramer (Glatiramer acetate)
[1] Glatiramer acetate (Glatiramer acetate) 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬
[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
93Glatiramer acetate 150mg enteric-coated (gastro-resistant) tablets[2] Acetate (Acetate ion),
Glatiramer (Glatiramer acetate)
[1] Glatiramer acetate (Glatiramer acetate) 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬
[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
94Glatiramer acetate 20 mg[2] Acetate (Acetate ion),
Glatiramer (Glatiramer acetate)
[1] Glatiramer acetate (Glatiramer acetate) 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬
[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
95Glatiramer acetate 20 mg, with mitoxantrone[3] Acetate (Acetate ion),
Glatiramer (Glatiramer acetate),
Mitoxantrone
[3] Mitoxantrone hydrochloride ,
Glatiramer acetate (Glatiramer acetate),
Mitoxantrone 💬
[20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬
[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
96Glatiramer Acetate 20 mg/0.5 mL[2] Acetate (Acetate ion),
Glatiramer (Glatiramer acetate)
[1] Glatiramer acetate (Glatiramer acetate) 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬
[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
97Glatiramer acetate 40 mg[2] Acetate (Acetate ion),
Glatiramer (Glatiramer acetate)
[1] Glatiramer acetate (Glatiramer acetate) 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬
[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
98Glatiramer Acetate [GA][2] Acetate (Acetate ion),
Glatiramer (Glatiramer acetate)
[1] Glatiramer acetate (Glatiramer acetate) 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬
[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
99Glatiramer acetate injection with oral cetirizine hydrochloride[3] Acetate (Acetate ion),
Cetirizine,
Glatiramer (Glatiramer acetate)
[3] Cetirizine hydrochloride ,
Glatiramer acetate (Glatiramer acetate),
Cetirizine 💬
[21] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G,
HRH1 💬
[36] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Calcium signaling pathway, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
100Glatiramer acetate with minocycline[3] Acetate (Acetate ion),
Glatiramer (Glatiramer acetate),
Minocycline
[3] Minocycline hydrochloride ,
Glatiramer acetate (Glatiramer acetate),
Minocycline 💬
[20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬
[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
101Glatiramer acetate, (Copaxone®)[2] Acetate (Acetate ion),
Glatiramer (Glatiramer acetate)
[1] Glatiramer acetate (Glatiramer acetate) 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬
[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
102Glatiramer Acetate, IFN-beta 1a (IM), IFN-beta 1a (Subcutaneous), and IFN-beta 1b[2] Acetate (Acetate ion),
Glatiramer (Glatiramer acetate)
[1] Glatiramer acetate (Glatiramer acetate) 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬
[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
103Glatiramer Acetate, N-Acetylcysteine[3] Acetate (Acetate ion),
Acetylcysteine,
Glatiramer (Glatiramer acetate)
[2] Acetylcysteine ,
Glatiramer acetate (Glatiramer acetate) 💬
[20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬
[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
104GLATIRAMER ACETATO
(Glatiramer acetate)
[1] Glatiramer (Glatiramer acetate)[1] Glatiramer acetate (Glatiramer acetate) 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬
[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
105Gonadorelin
(Gonadorelin acetate)
[1] Gonadorelin (Gonadorelin acetate)[3] Gonadorelin hydrochloride ,
Gonadorelin acetate (Gonadorelin acetate),
Gonadorelin 💬
[1] GNRHR 💬 [3] GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬[1] 76 💬
106Goserelin
(Goserelin acetate)
[1] Goserelin (Goserelin acetate)[2] Goserelin acetate (Goserelin acetate),
Goserelin 💬
[1] GNRHR 💬 [3] GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬[2] 1, 60 💬
107Goserelin Depot
(Goserelin acetate)
[1] Goserelin (Goserelin acetate)[2] Goserelin acetate (Goserelin acetate),
Goserelin 💬
[1] GNRHR 💬 [3] GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬[1] 60 💬
108Guanabenz
(Guanabenz acetate)
[1] Guanabenz (Guanabenz Acetate)[2] Guanabenz acetate (Guanabenz acetate),
Guanabenz 💬
[3] ADRA2A,
ADRA2B,
ADRA2C 💬
[4] Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[2] 2, 13 💬
109GUANABENZ ACETATO
(Guanabenz acetate)
[1] Guanabenz (Guanabenz Acetate)[2] Guanabenz acetate (Guanabenz acetate),
Guanabenz 💬
[3] ADRA2A,
ADRA2B,
ADRA2C 💬
[4] Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 2 💬
110Hematide, peginesatide
(Peginesatide acetate)
[1] Peginesatide (Peginesatide acetate)[2] Peginesatide ,
Peginesatide acetate (Peginesatide acetate) 💬
[1] EPOR 💬 [7] Cytokine-cytokine receptor interaction, Efferocytosis, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬[1] 283 💬
111High-dose intravenous methylprednisolone
(Methylprednisolone acetate)
[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone ,
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
112Histrelin
(Histrelin acetate)
[1] Histrelin (Histrelin acetate)[2] Histrelin acetate (Histrelin acetate),
Histrelin 💬
[1] GNRHR 💬 [3] GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬[1] 76 💬
113Histrelin Subcutaneous Implant
(Histrelin acetate)
[1] Histrelin (Histrelin acetate)[2] Histrelin acetate (Histrelin acetate),
Histrelin 💬
[1] GNRHR 💬 [3] GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬[1] 76 💬
114Human interferon beta-1a and glatiramer acetate[4] Acetate (Acetate ion),
Glatiramer (Glatiramer acetate),
Human interferon beta,
Interferon beta-1a
[3] Interferon beta ,
Glatiramer acetate (Glatiramer acetate),
Interferon beta-1a 💬
[22] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G,
IFNAR1,
IFNAR2 💬
[44] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Coronavirus disease, Cytokine-cytokine receptor interaction, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
115HYDROCORTISONE ACETATE[3] Acetate (Acetate ion),
Hydrocortisone,
Hydrocortisone acetate (Hydrocortisone 21-acetate)
[2] Hydrocortisone ,
Hydrocortisone acetate (Hydrocortisone acetate, HYDROCORTISONE ACETATE CREAM) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
116Hydrocortisone sodium acetate[3] Acetate (Acetate ion),
Hydrocortisone,
Sodium acetate (Sodium acetate trihydrate)
[2] Hydrocortisone ,
Sodium acetate (Sodium acetate, Sodium acetate hydrate, Sodium acetate trihydrate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 81 💬
117Hydroxocobalamin
(Hydroxocobalamin acetate)
[1] Hydroxocobalamin (Hydroxocobalamin acetate)[2] Hydroxocobalamin ,
Hydroxocobalamin acetate (Hydroxocobalamin acetate) 💬
--[3] 97, 246, 337 💬
118Hydroxocobalamin Chloride Injection
(Hydroxocobalamin acetate)
[1] Hydroxocobalamin (Hydroxocobalamin acetate)[2] Hydroxocobalamin ,
Hydroxocobalamin acetate (Hydroxocobalamin acetate) 💬
--[2] 246, 337 💬
119Hydroxocobalamin with Butyrate
(Hydroxocobalamin acetate)
[1] Hydroxocobalamin (Hydroxocobalamin acetate)[2] Hydroxocobalamin ,
Hydroxocobalamin acetate (Hydroxocobalamin acetate) 💬
--[1] 97 💬
120ICATIBANT
(Icatibant acetate)
[1] Icatibant (Icatibant acetate)[1] Icatibant acetate (Icatibant acetate) 💬 [1] BDKRB2 💬 [10] Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 65 💬
121Icatibant (30 mg)
(Icatibant acetate)
[1] Icatibant (Icatibant acetate)[1] Icatibant acetate (Icatibant acetate) 💬 [1] BDKRB2 💬 [10] Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 65 💬
122ICATIBANT ACETATE[2] Acetate (Acetate ion),
Icatibant (Icatibant acetate)
[1] Icatibant acetate (Icatibant acetate) 💬 [1] BDKRB2 💬 [10] Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 65 💬
123Icatibant Acetate (JAN)[2] Acetate (Acetate ion),
Icatibant (Icatibant acetate)
[1] Icatibant acetate (Icatibant acetate) 💬 [1] BDKRB2 💬 [10] Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 65 💬
124Icatibant acetate solution for injection 10 mg/ml[2] Acetate (Acetate ion),
Icatibant (Icatibant acetate)
[1] Icatibant acetate (Icatibant acetate) 💬 [1] BDKRB2 💬 [10] Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 65 💬
125Icatibant Injection (Icanticure®)
(Icatibant acetate)
[1] Icatibant (Icatibant acetate)[1] Icatibant acetate (Icatibant acetate) 💬 [1] BDKRB2 💬 [10] Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 65 💬
126Infliximab, methylprednisolone, methotrexate
(Methylprednisolone acetate)
[3] Infliximab,
Methotrexate,
Methylprednisolone (Methylprednisolone acetate)
[5] Methotrexate ,
Methylprednisolone ,
Methylprednisolone acetate (Methylprednisolone acetate),
Methotrexate sodium ,
Infliximab 💬
[4] DHFR,
DHFR2,
NR3C1,
TNF 💬
[70] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Folate transport and metabolism, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 46 💬
127Injectable Somatostatin Analogs (octreotide or lanreotide)
(Lanreotide acetate)
[3] Lanreotide (Lanreotide acetate),
Octreotide (Octreotide acetate),
Somatostatin (Somatostatin acetate)
[7] Octreotide ,
Octreotide acetate (Octreotide acetate),
Lanreotide acetate (Lanreotide acetate),
Octreotide pamoate ,
Octreotide acetate (Octreotide acetate),
Somatostatin ,
Octreotide hydrochloride 💬
[5] SSTR1,
SSTR2,
SSTR3,
SSTR4,
SSTR5 💬
[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
128Interferon or glatiramer acetate[2] Acetate (Acetate ion),
Glatiramer (Glatiramer acetate)
[1] Glatiramer acetate (Glatiramer acetate) 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬
[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
129Interferon-beta-1a (Avonex) plus methylprednisolone
(Methylprednisolone acetate)
[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone ,
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
130Interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab[12] Acetate (Acetate ion),
Alemtuzumab,
Cladribine,
Dimethyl fumarate,
Fingolimod,
Glatiramer (Glatiramer acetate),
Natalizumab,
Ocrelizumab,
Ofatumumab,
Ponesimod,
Rituximab,
Teriflunomide
[13] Cladribine ,
Alemtuzumab ,
Rituximab ,
Dimethyl fumarate ,
Fingolimod hydrochloride ,
Glatiramer acetate (Glatiramer acetate),
Ocrelizumab ,
Natalizumab ,
Ofatumumab ,
Fingolimod ,
Teriflunomide ,
Ponesimod ,
Fingolimod lauryl sulfate 💬
[26] DHODH,
HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G,
ITGA4,
KEAP1,
MS4A1,
RRM1,
S1PR1 💬
[58] Allograft rejection, Antigen processing and presentation, Arrhythmogenic right ventricular cardiomyopathy, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Chemical carcinogenesis - reactive oxygen species, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Drug metabolism - other enzymes, ECM-receptor interaction, Efferocytosis, Endocytosis, Epstein-Barr virus infection, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Glutathione metabolism, Graft-versus-host disease, Hematopoietic cell lineage, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Inflammatory bowel disease, Influenza A, Integrin signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Leukocyte transendothelial migration, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Pathways in cancer, Phagocytosis, Purine metabolism, Pyrimidine metabolism, Regulation of actin cytoskeleton, Rheumatoid arthritis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Ubiquitin mediated proteolysis, Viral carcinogenesis, Viral myocarditis, Yersinia infection 💬[1] 13 💬
131Intra-articular Compound Betamethasone
(Betamethasone acetate)
[1] Betamethasone (Betamethasone acetate)[6] Betamethasone ,
Betamethasone sodium phosphate ,
Betamethasone valerate ,
Betamethasone acetate (Betamethasone acetate),
Betamethasone dipropionate ,
Betamethasone benzoate 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
132Intraarticular betamethasone
(Betamethasone acetate)
[1] Betamethasone (Betamethasone acetate)[6] Betamethasone ,
Betamethasone sodium phosphate ,
Betamethasone valerate ,
Betamethasone acetate (Betamethasone acetate),
Betamethasone dipropionate ,
Betamethasone benzoate 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
133Intravenous (i.v.) methylprednisolone 1000 mg, total 9
(Methylprednisolone acetate)
[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone ,
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 222, 223 💬
134Intravenous Methylprednisolone
(Methylprednisolone acetate)
[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone ,
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[3] 13, 97, 145 💬
135Intravenous Methylprednisolone (IVMP)
(Methylprednisolone acetate)
[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone ,
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
136Intravenous methylprednisolone (IVMP) and Efgartigimod
(Methylprednisolone acetate)
[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone ,
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
137IV methylprednisolone
(Methylprednisolone acetate)
[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone ,
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
138IV methylprednisolone (steroids)
(Methylprednisolone acetate)
[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone ,
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
139L-Lysine N acetylcysteinate
(Lysine acetate, L-Lysine acetate)
[1] Lysine (Lysine acetate)[4] Lysine acetate (Lysine acetate, L-Lysine acetate),
Lysine hydrochloride ,
Lysine ,
Lysine hydrochloride 💬
--[1] 299 💬
140L-Lysine N-acetylcysteinate
(Lysine acetate, L-Lysine acetate)
[1] Lysine (Lysine acetate)[4] Lysine acetate (Lysine acetate, L-Lysine acetate),
Lysine hydrochloride ,
Lysine ,
Lysine hydrochloride 💬
--[1] 299 💬
141L-Lysine- N-acetylcysteinate
(Lysine acetate, L-Lysine acetate)
[1] Lysine (Lysine acetate)[4] Lysine acetate (Lysine acetate, L-Lysine acetate),
Lysine hydrochloride ,
Lysine ,
Lysine hydrochloride 💬
--[1] 299 💬
142L-Lysine-N-acetyl-L-cysteinate
(Lysine acetate, L-Lysine acetate)
[1] Lysine (Lysine acetate)[4] Lysine acetate (Lysine acetate, L-Lysine acetate),
Lysine hydrochloride ,
Lysine ,
Lysine hydrochloride 💬
--[1] 299 💬
143L-Lysine-N-acetylcysteinate
(Lysine acetate, L-Lysine acetate)
[1] Lysine (Lysine acetate)[4] Lysine acetate (Lysine acetate, L-Lysine acetate),
Lysine hydrochloride ,
Lysine ,
Lysine hydrochloride 💬
--[1] 299 💬
144L-Lysyl-D-Prolyl-L-Threonine Acetate[2] Acetate (Acetate ion),
Threonine
[1] Threonine 💬 --[1] 97 💬
145L-Lysyl-D-Prolyl-LThreonine acetate, lyophilisate[1] Acetate (Acetate ion)---[1] 97 💬
146Lanreotide
(Lanreotide acetate)
[1] Lanreotide (Lanreotide acetate)[1] Lanreotide acetate (Lanreotide acetate) 💬 [2] SSTR2,
SSTR5 💬
[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[5] 67, 73, 77, 85, 298 💬
147Lanreotide (Autogel formulation)
(Lanreotide acetate)
[1] Lanreotide (Lanreotide acetate)[1] Lanreotide acetate (Lanreotide acetate) 💬 [2] SSTR2,
SSTR5 💬
[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
148Lanreotide (Autogel formulation), duration of treatment 24-56 weeks, depending on dose interval
(Lanreotide acetate)
[1] Lanreotide (Lanreotide acetate)[1] Lanreotide acetate (Lanreotide acetate) 💬 [2] SSTR2,
SSTR5 💬
[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
149Lanreotide (Autogel formulation), duration of treatment 46-48 weeks
(Lanreotide acetate)
[1] Lanreotide (Lanreotide acetate)[1] Lanreotide acetate (Lanreotide acetate) 💬 [2] SSTR2,
SSTR5 💬
[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
150Lanreotide 60Mg Solution for Injection
(Lanreotide acetate)
[1] Lanreotide (Lanreotide acetate)[1] Lanreotide acetate (Lanreotide acetate) 💬 [2] SSTR2,
SSTR5 💬
[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
151LANREOTIDE ACETATE[2] Acetate (Acetate ion),
Lanreotide (Lanreotide acetate)
[1] Lanreotide acetate (Lanreotide acetate) 💬 [2] SSTR2,
SSTR5 💬
[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[4] 67, 77, 85, 298 💬
152LANREOTIDE ACETATO
(Lanreotide acetate)
[1] Lanreotide (Lanreotide acetate)[1] Lanreotide acetate (Lanreotide acetate) 💬 [2] SSTR2,
SSTR5 💬
[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
153Lanreotide ATG
(Lanreotide acetate)
[1] Lanreotide (Lanreotide acetate)[1] Lanreotide acetate (Lanreotide acetate) 💬 [2] SSTR2,
SSTR5 💬
[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
154Lanreotide ATG 120mg
(Lanreotide acetate)
[1] Lanreotide (Lanreotide acetate)[1] Lanreotide acetate (Lanreotide acetate) 💬 [2] SSTR2,
SSTR5 💬
[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
155Lanreotide autogel
(Lanreotide acetate)
[1] Lanreotide (Lanreotide acetate)[1] Lanreotide acetate (Lanreotide acetate) 💬 [2] SSTR2,
SSTR5 💬
[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
156Lanreotide Autogel 120 mg
(Lanreotide acetate)
[1] Lanreotide (Lanreotide acetate)[1] Lanreotide acetate (Lanreotide acetate) 💬 [2] SSTR2,
SSTR5 💬
[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
157Lanreotide Autogel 120mg
(Lanreotide acetate)
[1] Lanreotide (Lanreotide acetate)[1] Lanreotide acetate (Lanreotide acetate) 💬 [2] SSTR2,
SSTR5 💬
[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
158Lanreotide Autogel and Octreotide LAR
(Lanreotide acetate)
[2] Lanreotide (Lanreotide acetate),
Octreotide (Octreotide acetate)
[6] Octreotide ,
Octreotide acetate (Octreotide acetate),
Lanreotide acetate (Lanreotide acetate),
Octreotide pamoate ,
Octreotide acetate (Octreotide acetate),
Octreotide hydrochloride 💬
[2] SSTR2,
SSTR5 💬
[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
159Lanreotide Autogel®
(Lanreotide acetate)
[1] Lanreotide (Lanreotide acetate)[1] Lanreotide acetate (Lanreotide acetate) 💬 [2] SSTR2,
SSTR5 💬
[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
160Lanreotide PRF
(Lanreotide acetate)
[1] Lanreotide (Lanreotide acetate)[1] Lanreotide acetate (Lanreotide acetate) 💬 [2] SSTR2,
SSTR5 💬
[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
161Lanreotide-Autogel 120 mg
(Lanreotide acetate)
[1] Lanreotide (Lanreotide acetate)[1] Lanreotide acetate (Lanreotide acetate) 💬 [2] SSTR2,
SSTR5 💬
[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
162Lapaquistat acetate and current lipid-lowering treatment[2] Acetate (Acetate ion),
Lapaquistat
---[1] 79 💬
163Lefamulin
(Lefamulin acetate)
[1] Lefamulin (Lefamulin acetate)[2] Lefamulin ,
Lefamulin acetate (Lefamulin acetate) 💬
--[1] 299 💬
164Leuprolide
(Leuprolide acetate, Leuprorelin acetate, LEUPROLIDE ACETATE DEPOT)
[1] Leuprolide (Leuprolide acetate)[3] Leuprolide acetate (Leuprolide acetate, Leuprorelin acetate, LEUPROLIDE ACETATE DEPOT),
Leuprolide ,
Leuprolide mesylate 💬
[1] GNRHR 💬 [3] GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬[5] 1, 2, 3, 51, 76 💬
165Leuprolide (GnRH agonists)
(Leuprolide acetate, Leuprorelin acetate, LEUPROLIDE ACETATE DEPOT)
[1] Leuprolide (Leuprolide acetate)[3] Leuprolide acetate (Leuprolide acetate, Leuprorelin acetate, LEUPROLIDE ACETATE DEPOT),
Leuprolide ,
Leuprolide mesylate 💬
[1] GNRHR 💬 [3] GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬[1] 76 💬
166Leuprolide Acetate (LA)[2] Acetate (Acetate ion),
Leuprolide (Leuprolide acetate)
[3] Leuprolide acetate (Leuprolide acetate, Leuprorelin acetate, LEUPROLIDE ACETATE DEPOT),
Leuprolide ,
Leuprolide mesylate 💬
[1] GNRHR 💬 [3] GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬[1] 76 💬
167Leuprolide Acetate 11.25 MG/ML[2] Acetate (Acetate ion),
Leuprolide (Leuprolide acetate)
[3] Leuprolide acetate (Leuprolide acetate, Leuprorelin acetate, LEUPROLIDE ACETATE DEPOT),
Leuprolide ,
Leuprolide mesylate 💬
[1] GNRHR 💬 [3] GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬[1] 76 💬
168Leuprolide Acetate 3 Month Depot[2] Acetate (Acetate ion),
Leuprolide (Leuprolide acetate)
[3] Leuprolide acetate (Leuprolide acetate, Leuprorelin acetate, LEUPROLIDE ACETATE DEPOT),
Leuprolide ,
Leuprolide mesylate 💬
[1] GNRHR 💬 [3] GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬[1] 76 💬
169Leuprolide Acetate 45 mg[2] Acetate (Acetate ion),
Leuprolide (Leuprolide acetate)
[3] Leuprolide acetate (Leuprolide acetate, Leuprorelin acetate, LEUPROLIDE ACETATE DEPOT),
Leuprolide ,
Leuprolide mesylate 💬
[1] GNRHR 💬 [3] GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬[1] 76 💬
170Leuprolide acetate depot[2] Acetate (Acetate ion),
Leuprolide (Leuprolide acetate)
[3] Leuprolide acetate (Leuprolide acetate, Leuprorelin acetate, LEUPROLIDE ACETATE DEPOT),
Leuprolide ,
Leuprolide mesylate 💬
[1] GNRHR 💬 [3] GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬[1] 76 💬
171Leuprolide Mesylate, Subcutaneous injection of 42 mg Leuprolide
(Leuprolide acetate, Leuprorelin acetate, LEUPROLIDE ACETATE DEPOT)
[1] Leuprolide (Leuprolide acetate)[3] Leuprolide acetate (Leuprolide acetate, Leuprorelin acetate, LEUPROLIDE ACETATE DEPOT),
Leuprolide ,
Leuprolide mesylate 💬
[1] GNRHR 💬 [3] GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬[1] 76 💬
172Leuprorelin Acetate[2] Acetate (Acetate ion),
Leuprolide (Leuprolide acetate)
[3] Leuprolide acetate (Leuprolide acetate, Leuprorelin acetate, LEUPROLIDE ACETATE DEPOT),
Leuprolide ,
Leuprolide mesylate 💬
[1] GNRHR 💬 [3] GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬[2] 1, 76 💬
173Leuprorelin Acetate 3.75mg Injection[1] Acetate (Acetate ion)---[1] 76 💬
174Leuprorelin Acetate Depot 3M[1] Acetate (Acetate ion)---[1] 76 💬
175Linaclotide
(Linaclotide acetate)
[1] Linaclotide (Linaclotide acetate)[2] Linaclotide acetate (Linaclotide acetate),
Linaclotide 💬
[1] GUCY2C 💬 [2] Hormone signaling, Purine metabolism 💬[3] 6, 97, 299 💬
176Linaclotide 290 micrograms
(Linaclotide acetate)
[1] Linaclotide (Linaclotide acetate)[2] Linaclotide acetate (Linaclotide acetate),
Linaclotide 💬
[1] GUCY2C 💬 [2] Hormone signaling, Purine metabolism 💬[1] 299 💬
177Loestrin (norethindrone acetate and ethinyl estradiol)[2] Acetate (Acetate ion),
Estradiol
[2] Estradiol ,
Estradiol hemihydrate 💬
[2] ESR1,
ESR2 💬
[10] Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬[1] 299 💬
178Loestrin 1.5/30 (1.5 mg norethindrone acetate/30 µg ethinyl estradiol)[2] Acetate (Acetate ion),
Estradiol
[2] Estradiol ,
Estradiol hemihydrate 💬
[2] ESR1,
ESR2 💬
[10] Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬[2] 46, 49 💬
179Luphere depot 3.75mg(Leuprolide acetate 3.75mg)[2] Acetate (Acetate ion),
Leuprolide (Leuprolide acetate)
[3] Leuprolide acetate (Leuprolide acetate, Leuprorelin acetate, LEUPROLIDE ACETATE DEPOT),
Leuprolide ,
Leuprolide mesylate 💬
[1] GNRHR 💬 [3] GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬[1] 76 💬
180Lupron (leuprolide acetate)[2] Acetate (Acetate ion),
Leuprolide (Leuprolide acetate)
[3] Leuprolide acetate (Leuprolide acetate, Leuprorelin acetate, LEUPROLIDE ACETATE DEPOT),
Leuprolide ,
Leuprolide mesylate 💬
[1] GNRHR 💬 [3] GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬[1] 76 💬
181Lysine
(Lysine acetate, L-Lysine acetate)
[1] Lysine (Lysine acetate)[4] Lysine acetate (Lysine acetate, L-Lysine acetate),
Lysine hydrochloride ,
Lysine ,
Lysine hydrochloride 💬
--[4] 13, 97, 228, 299 💬
182Lysine-D-Proline-Threonine
(Lysine acetate, L-Lysine acetate)
[4] D-Proline,
Lysine (Lysine acetate),
Proline,
Threonine
[6] Proline ,
Threonine ,
Lysine acetate (Lysine acetate, L-Lysine acetate),
Lysine hydrochloride ,
Lysine ,
Lysine hydrochloride 💬
--[1] 97 💬
183Megadose oral methylprednisolone
(Methylprednisolone acetate)
[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone ,
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
184Megestrol acetate[3] Acetate (Acetate ion),
Megestrol,
Megestrol acetate (6-Methyl-17alpha-hydroxy-delta-progesterone acetate)
[2] Megestrol acetate (Megestrol acetate),
Megestrol 💬
[1] PGR 💬 [5] Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬[1] 76 💬
185Megestrol Acetate Tablet[3] Acetate (Acetate ion),
Megestrol,
Megestrol acetate (6-Methyl-17alpha-hydroxy-delta-progesterone acetate)
[2] Megestrol acetate (Megestrol acetate),
Megestrol 💬
[1] PGR 💬 [5] Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬[1] 76 💬
186Methotrexate + Methylprednisolone
(Methylprednisolone acetate)
[2] Methotrexate,
Methylprednisolone (Methylprednisolone acetate)
[4] Methotrexate ,
Methylprednisolone ,
Methylprednisolone acetate (Methylprednisolone acetate),
Methotrexate sodium 💬
[3] DHFR,
DHFR2,
NR3C1 💬
[4] Folate biosynthesis, Folate transport and metabolism, Neuroactive ligand-receptor interaction, One carbon pool by folate 💬[1] 46 💬
187Methylprednisolone
(Methylprednisolone acetate)
[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone ,
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[51] 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 111, 127, 145, 162, 164, 211, 222, 223, 224, 271, 283, 284, 285, 296, 300 💬
188Methylprednisolone (Corticosteroid)
(Methylprednisolone acetate)
[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone ,
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 49 💬
189Methylprednisolone (drug)
(Methylprednisolone acetate)
[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone ,
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 13, 66 💬
190Methylprednisolone (MP)
(Methylprednisolone acetate)
[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone ,
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[3] 60, 65, 285 💬
191Methylprednisolone (MP) or prednisone (pred)
(Methylprednisolone acetate)
[2] Methylprednisolone (Methylprednisolone acetate),
Prednisone
[3] Methylprednisolone ,
Prednisone ,
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 66 💬
192Methylprednisolone (or other glucocorticoid)
(Methylprednisolone acetate)
[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone ,
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 43 💬
193Methylprednisolone (Solu-Medrol)
(Methylprednisolone acetate)
[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone ,
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 14 💬
194Methylprednisolone 1250 mg/24h x3 days
(Methylprednisolone acetate)
[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone ,
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
195METHYLPREDNISOLONE ACETATE[2] Acetate (Acetate ion),
Methylprednisolone (Methylprednisolone acetate)
[2] Methylprednisolone ,
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 46, 51 💬
196Methylprednisolone and azathioprine
(Methylprednisolone acetate)
[2] Azathioprine,
Methylprednisolone (Methylprednisolone acetate)
[4] Azathioprine ,
Methylprednisolone ,
Methylprednisolone acetate (Methylprednisolone acetate),
Azathioprine sodium 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 93, 95 💬
197Methylprednisolone and IVIG
(Methylprednisolone acetate)
[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone ,
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 63 💬
198Methylprednisolone and Mycophenolate mofetil
(Methylprednisolone acetate)
[2] Methylprednisolone (Methylprednisolone acetate),
Mycophenolate mofetil
[4] Methylprednisolone ,
Mycophenolate mofetil ,
Methylprednisolone acetate (Methylprednisolone acetate),
Mycophenolate mofetil hydrochloride 💬
[3] IMPDH1,
IMPDH2,
NR3C1 💬
[3] Drug metabolism - other enzymes, Neuroactive ligand-receptor interaction, Purine metabolism 💬[2] 93, 95 💬
199Methylprednisolone bolus IV 15 mg/kg/d for 3 days.
(Methylprednisolone acetate)
[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone ,
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 84 💬
200Methylprednisolone hemisuccinate
(Methylprednisolone acetate)
[2] Methylprednisolone (Methylprednisolone acetate),
Methylprednisolone hemisuccinate
[4] Methylprednisolone ,
Methylprednisolone sodium succinate ,
Methylprednisolone acetate (Methylprednisolone acetate),
Methylprednisolone hemisuccinate 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 13, 85 💬
201Methylprednisolone IV
(Methylprednisolone acetate)
[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone ,
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
202METHYLPREDNISOLONE MYLAN Générique
(Methylprednisolone acetate)
[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone ,
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 66 💬
203Methylprednisolone or budesonide
(Methylprednisolone acetate)
[2] Budesonide,
Methylprednisolone (Methylprednisolone acetate)
[3] Budesonide ,
Methylprednisolone ,
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 96 💬
204Methylprednisolone or Prednisolone
(Methylprednisolone acetate)
[2] Methylprednisolone (Methylprednisolone acetate),
Prednisolone
[3] Methylprednisolone ,
Prednisolone ,
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 65 💬
205Methylprednisolone PO
(Methylprednisolone acetate)
[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone ,
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
206Methylprednisolone pulse
(Methylprednisolone acetate)
[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone ,
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 66, 223 💬
207Methylprednisolone pulses plus prednisone versus Cyclosporine A
(Methylprednisolone acetate)
[3] Cyclosporine,
Methylprednisolone (Methylprednisolone acetate),
Prednisone
[4] Cyclosporine ,
Methylprednisolone ,
Prednisone ,
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[6] NR3C1,
PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬
[34] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[1] 223 💬
208METHYLPREDNISOLONE SODIUM HEMISUCCINATE
(Methylprednisolone acetate)
[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone ,
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[3] 13, 85, 97 💬
209METHYLPREDNISOLONE SODIUM SUCCINATE
(Methylprednisolone acetate)
[3] Methylprednisolone (Methylprednisolone acetate),
Methylprednisolone hemisuccinate,
Succinic acid
[4] Methylprednisolone ,
Methylprednisolone sodium succinate ,
Methylprednisolone acetate (Methylprednisolone acetate),
Methylprednisolone hemisuccinate 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[7] 13, 46, 49, 50, 51, 211, 222 💬
210Methylprednisolone succinate
(Methylprednisolone acetate)
[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone ,
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 13, 66 💬
211Methylprednisolone(intravenously in the 1st-2nd-3rd month )
(Methylprednisolone acetate)
[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone ,
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 66, 223 💬
212Methylprednisolone(intravenously in the 1st-3rd-5th month)
(Methylprednisolone acetate)
[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone ,
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 66, 223 💬
213N''-[(E)-[(2E)-3-[1-(2-nitrophenyl)-1H-pyrrol-2-yl]prop-2-en-1-ylidene]amino]guanidinium acetate[1] Acetate (Acetate ion)---[1] 46 💬
214Nasal Methylprednisolone (MT)
(Methylprednisolone acetate)
[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone ,
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
215Nomegestrol acetate[3] Acetate (Acetate ion),
Nomegestrol,
Nomegestrol acetate (Nomegestrol acetate)
[2] Nomegestrol ,
Nomegestrol acetate (Nomegestrol acetate) 💬
[1] PGR 💬 [5] Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬[1] 13 💬
216Norethindrone Acetate-Ethinyl Estradiol[2] Acetate (Acetate ion),
Estradiol
[2] Estradiol ,
Estradiol hemihydrate 💬
[2] ESR1,
ESR2 💬
[10] Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬[1] 78 💬
217NP-201 acetate injection (Part A)[1] Acetate (Acetate ion)---[1] 97 💬
218Octreotide
(Octreotide acetate)
[1] Octreotide (Octreotide acetate)[5] Octreotide ,
Octreotide acetate (Octreotide acetate),
Octreotide pamoate ,
Octreotide acetate (Octreotide acetate),
Octreotide hydrochloride 💬
[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[8] 67, 75, 77, 84, 85, 89, 193, 227 💬
219Octreotide a azione pronta 0,1 mg
(Octreotide acetate)
[1] Octreotide (Octreotide acetate)[5] Octreotide ,
Octreotide acetate (Octreotide acetate),
Octreotide pamoate ,
Octreotide acetate (Octreotide acetate),
Octreotide hydrochloride 💬
[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 227 💬
220OCTREOTIDE ACETATE[2] Acetate (Acetate ion),
Octreotide (Octreotide acetate)
[5] Octreotide ,
Octreotide acetate (Octreotide acetate),
Octreotide pamoate ,
Octreotide acetate (Octreotide acetate),
Octreotide hydrochloride 💬
[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[2] 77, 227 💬
221Octreotide acetate 30 mg suspension[2] Acetate (Acetate ion),
Octreotide (Octreotide acetate)
[5] Octreotide ,
Octreotide acetate (Octreotide acetate),
Octreotide pamoate ,
Octreotide acetate (Octreotide acetate),
Octreotide hydrochloride 💬
[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
222Octreotide acetate and cabergoline/Octrotide and Somavert[3] Acetate (Acetate ion),
Cabergoline,
Octreotide (Octreotide acetate)
[6] Octreotide ,
Cabergoline ,
Octreotide acetate (Octreotide acetate),
Octreotide pamoate ,
Octreotide acetate (Octreotide acetate),
Octreotide hydrochloride 💬
[3] DRD2,
PRL,
SSTR2 💬
[16] Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 77 💬
223Octreotide acetate LAR[2] Acetate (Acetate ion),
Octreotide (Octreotide acetate)
[5] Octreotide ,
Octreotide acetate (Octreotide acetate),
Octreotide pamoate ,
Octreotide acetate (Octreotide acetate),
Octreotide hydrochloride 💬
[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
224Octreotide Acetate Microspheres for Injection injection[2] Acetate (Acetate ion),
Octreotide (Octreotide acetate)
[5] Octreotide ,
Octreotide acetate (Octreotide acetate),
Octreotide pamoate ,
Octreotide acetate (Octreotide acetate),
Octreotide hydrochloride 💬
[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
225Octreotide acetate prolonged release, 30 mg[2] Acetate (Acetate ion),
Octreotide (Octreotide acetate)
[5] Octreotide ,
Octreotide acetate (Octreotide acetate),
Octreotide pamoate ,
Octreotide acetate (Octreotide acetate),
Octreotide hydrochloride 💬
[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
226OCTREOTIDE ACETATO
(Octreotide acetate)
[1] Octreotide (Octreotide acetate)[5] Octreotide ,
Octreotide acetate (Octreotide acetate),
Octreotide pamoate ,
Octreotide acetate (Octreotide acetate),
Octreotide hydrochloride 💬
[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[2] 77, 227 💬
227Octreotide capsules
(Octreotide acetate)
[1] Octreotide (Octreotide acetate)[5] Octreotide ,
Octreotide acetate (Octreotide acetate),
Octreotide pamoate ,
Octreotide acetate (Octreotide acetate),
Octreotide hydrochloride 💬
[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
228Octreotide FluidCrystal® injection depot
(Octreotide acetate)
[1] Octreotide (Octreotide acetate)[5] Octreotide ,
Octreotide acetate (Octreotide acetate),
Octreotide pamoate ,
Octreotide acetate (Octreotide acetate),
Octreotide hydrochloride 💬
[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
229OCTREOTIDE HYDROCHLORIDE
(Octreotide acetate)
[1] Octreotide (Octreotide acetate)[5] Octreotide ,
Octreotide acetate (Octreotide acetate),
Octreotide pamoate ,
Octreotide acetate (Octreotide acetate),
Octreotide hydrochloride 💬
[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
230Octreotide Implant
(Octreotide acetate)
[1] Octreotide (Octreotide acetate)[5] Octreotide ,
Octreotide acetate (Octreotide acetate),
Octreotide pamoate ,
Octreotide acetate (Octreotide acetate),
Octreotide hydrochloride 💬
[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
231Octreotide LAR
(Octreotide acetate)
[1] Octreotide (Octreotide acetate)[5] Octreotide ,
Octreotide acetate (Octreotide acetate),
Octreotide pamoate ,
Octreotide acetate (Octreotide acetate),
Octreotide hydrochloride 💬
[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[3] 67, 77, 227 💬
232Octreotide LAR / Sandostatin LAR (LAR=long acting release)
(Octreotide acetate)
[1] Octreotide (Octreotide acetate)[5] Octreotide ,
Octreotide acetate (Octreotide acetate),
Octreotide pamoate ,
Octreotide acetate (Octreotide acetate),
Octreotide hydrochloride 💬
[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 84 💬
233Octreotide LAR 30 MG Injection
(Octreotide acetate)
[1] Octreotide (Octreotide acetate)[5] Octreotide ,
Octreotide acetate (Octreotide acetate),
Octreotide pamoate ,
Octreotide acetate (Octreotide acetate),
Octreotide hydrochloride 💬
[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
234Octreotide LAR 30mg
(Octreotide acetate)
[1] Octreotide (Octreotide acetate)[5] Octreotide ,
Octreotide acetate (Octreotide acetate),
Octreotide pamoate ,
Octreotide acetate (Octreotide acetate),
Octreotide hydrochloride 💬
[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
235Octreotide subcutaneous depot
(Octreotide acetate)
[1] Octreotide (Octreotide acetate)[5] Octreotide ,
Octreotide acetate (Octreotide acetate),
Octreotide pamoate ,
Octreotide acetate (Octreotide acetate),
Octreotide hydrochloride 💬
[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
236Octreotide-LAR
(Octreotide acetate)
[1] Octreotide (Octreotide acetate)[5] Octreotide ,
Octreotide acetate (Octreotide acetate),
Octreotide pamoate ,
Octreotide acetate (Octreotide acetate),
Octreotide hydrochloride 💬
[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[2] 67, 77 💬
237Octreotide-LAR or lanreotide
(Lanreotide acetate)
[2] Lanreotide (Lanreotide acetate),
Octreotide (Octreotide acetate)
[6] Octreotide ,
Octreotide acetate (Octreotide acetate),
Lanreotide acetate (Lanreotide acetate),
Octreotide pamoate ,
Octreotide acetate (Octreotide acetate),
Octreotide hydrochloride 💬
[2] SSTR2,
SSTR5 💬
[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
238Oral 5-ASA+/-topical 5-ASA+IV corticosteroids / PO Methylprednisolone
(Methylprednisolone acetate)
[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone ,
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
239Oral Methylprednisolone 625 mg/24h x3 days
(Methylprednisolone acetate)
[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone ,
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
240Other: Exposure to methylprednisolone during pregnancy
(Methylprednisolone acetate)
[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone ,
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
241Other: glatiramer acetate[2] Acetate (Acetate ion),
Glatiramer (Glatiramer acetate)
[1] Glatiramer acetate (Glatiramer acetate) 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬
[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
242Other: Glatiramer acetate, Interferons (intramuscular, subcutaneous, pegylated) Teriflunomide, Fumarates (dimethyl, diroximel, monomethyl) Fingolimod, Siponimod, Ozanimod, Ponesimod[7] Acetate (Acetate ion),
Fingolimod,
Glatiramer (Glatiramer acetate),
Ozanimod,
Ponesimod,
Siponimod,
Teriflunomide
[10] Fingolimod hydrochloride ,
Glatiramer acetate (Glatiramer acetate),
Fingolimod ,
Teriflunomide ,
Ozanimod hydrochloride ,
Ozanimod ,
Siponimod fumarate ,
Ponesimod ,
Siponimod ,
Fingolimod lauryl sulfate 💬
[26] DHODH,
HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G,
S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬
[37] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Efferocytosis, Endocytosis, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Phagocytosis, Pyrimidine metabolism, Rheumatoid arthritis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
243Other: IV Methylprednisolone administration
(Methylprednisolone acetate)
[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone ,
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
244Pasireotide (SOM230), Octreotide (Sandostatin)
(Octreotide acetate)
[2] Octreotide (Octreotide acetate),
Pasireotide (Pasireotide acetate)
[8] Octreotide ,
Octreotide acetate (Octreotide acetate),
Octreotide pamoate ,
Octreotide acetate (Octreotide acetate),
Pasireotide ,
Pasireotide diaspartate ,
Pasireotide pamoate ,
Octreotide hydrochloride 💬
[4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬
[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
245Peginesatide
(Peginesatide acetate)
[1] Peginesatide (Peginesatide acetate)[2] Peginesatide ,
Peginesatide acetate (Peginesatide acetate) 💬
[1] EPOR 💬 [7] Cytokine-cytokine receptor interaction, Efferocytosis, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬[1] 283 💬
246PHENYLCYCLOPROPYLAMINE DERIVATIVES AND DUAL LSD1/MAO-B (LYSINE-SPECIFIC DEMETHYLASE 1 AND MONOAMINE OXIDASE-B) INHIBITOR
(Lysine acetate, L-Lysine acetate)
[1] Lysine (Lysine acetate)[4] Lysine acetate (Lysine acetate, L-Lysine acetate),
Lysine hydrochloride ,
Lysine ,
Lysine hydrochloride 💬
--[1] 13 💬
247Phosphate and betamethasone acetate, 2 mL.[2] Acetate (Acetate ion),
Betamethasone (Betamethasone acetate)
[6] Betamethasone ,
Betamethasone sodium phosphate ,
Betamethasone valerate ,
Betamethasone acetate (Betamethasone acetate),
Betamethasone dipropionate ,
Betamethasone benzoate 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 235 💬
248Platform therapies (Dimethyl Fumarate, Teriflunomide, Glatiramer Acetate, Beta-interferons)[4] Acetate (Acetate ion),
Dimethyl fumarate,
Glatiramer (Glatiramer acetate),
Teriflunomide
[3] Dimethyl fumarate ,
Glatiramer acetate (Glatiramer acetate),
Teriflunomide 💬
[22] DHODH,
HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G,
KEAP1 💬
[39] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Chemical carcinogenesis - reactive oxygen species, Endocytosis, Epstein-Barr virus infection, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Parkinson disease, Pathways in cancer, Phagocytosis, Pyrimidine metabolism, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Ubiquitin mediated proteolysis, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
249Plovamer acetate[1] Acetate (Acetate ion)---[1] 13 💬
250Plovamer acetate 0.5 milligram (mg)[1] Acetate (Acetate ion)---[1] 13 💬
251Plovamer acetate 10 mg[1] Acetate (Acetate ion)---[1] 13 💬
252Plovamer acetate 20 mg[1] Acetate (Acetate ion)---[1] 13 💬
253Plovamer acetate 3 mg[1] Acetate (Acetate ion)---[1] 13 💬
254POLY(OXY-1,2-ETHANEDIYL), ALPHA-HYDRO-OMEGA-METHOXY, ETHER WITH N-[[[2-[[6-[[1-[3-[[3-(2,3-DIHYDROXYPROPOXY)PROPYL]AMINO]-3-OXOPROPYL]-2,5-DIOXO-3-PYRROLIDINYL]THIO]HEXYL]AMINO]ETHYL]AMINO]CARBONYL]-2-METHYLALANYL-TERIPARATIDE (2:1)
(Teriparatide acetate)
[1] Teriparatide (Teriparatide acetate)[3] Teriparatide acetate (Teriparatide acetate),
Teriparatide ,
Teriparatide acetate (Teriparatide acetate, Teriparatide acetate hydrate) 💬
[1] PTH1R 💬 [4] Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬[1] 235 💬
255Pre-treatment with octreotide
(Octreotide acetate)
[1] Octreotide (Octreotide acetate)[5] Octreotide ,
Octreotide acetate (Octreotide acetate),
Octreotide pamoate ,
Octreotide acetate (Octreotide acetate),
Octreotide hydrochloride 💬
[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
256PREDNISOLONE ACETATE[3] Acetate (Acetate ion),
Prednisolone,
Prednisolone acetate (Prednisolone acetate)
[2] Prednisolone ,
Prednisolone acetate (Prednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 222, 223 💬
257Prednisone (and methylprednisolone)
(Methylprednisolone acetate)
[2] Methylprednisolone (Methylprednisolone acetate),
Prednisone
[3] Methylprednisolone ,
Prednisone ,
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 43 💬
258Prednisone acetate[3] Acetate (Acetate ion),
Prednisone,
Prednisone acetate (Prednisone-21-acetate)
[2] Prednisone ,
Prednisone acetate (Prednisone acetate, Prednisone 21-acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[9] 35, 40, 46, 49, 63, 66, 162, 222, 224 💬
259Prednisone Acetate Tablets[3] Acetate (Acetate ion),
Prednisone,
Prednisone acetate (Prednisone-21-acetate)
[2] Prednisone ,
Prednisone acetate (Prednisone acetate, Prednisone 21-acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 40, 224 💬
260Prednisone, methylprednisolone,cyclophosphamides
(Methylprednisolone acetate)
[2] Methylprednisolone (Methylprednisolone acetate),
Prednisone
[3] Methylprednisolone ,
Prednisone ,
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[3] 42, 43, 45 💬
261Preoperative lanreotide treatment
(Lanreotide acetate)
[1] Lanreotide (Lanreotide acetate)[1] Lanreotide acetate (Lanreotide acetate) 💬 [2] SSTR2,
SSTR5 💬
[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
262Preventative (Prophylactic) Medication - Corticosteroids: Methylprednisolone
(Methylprednisolone acetate)
[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone ,
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 2 💬
263Rituximab plus methylprednisolone
(Methylprednisolone acetate)
[2] Methylprednisolone (Methylprednisolone acetate),
Rituximab
[3] Methylprednisolone ,
Methylprednisolone acetate (Methylprednisolone acetate),
Rituximab 💬
[2] MS4A1,
NR3C1 💬
[2] Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬[1] 63 💬
264Sandostatin (Octreotide Acetate)[2] Acetate (Acetate ion),
Octreotide (Octreotide acetate)
[5] Octreotide ,
Octreotide acetate (Octreotide acetate),
Octreotide pamoate ,
Octreotide acetate (Octreotide acetate),
Octreotide hydrochloride 💬
[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
265Sandostatin LAR ® (octreotide acetate LAR) 30 MG[2] Acetate (Acetate ion),
Octreotide (Octreotide acetate)
[5] Octreotide ,
Octreotide acetate (Octreotide acetate),
Octreotide pamoate ,
Octreotide acetate (Octreotide acetate),
Octreotide hydrochloride 💬
[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
266Setmelanotide
(Setmelanotide acetate)
[1] Setmelanotide (Setmelanotide acetate)[2] Setmelanotide ,
Setmelanotide acetate (Setmelanotide acetate) 💬
[1] MC4R 💬 [3] Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[5] 134, 193, 202, 236, 265 💬
267Sodium acetate[2] Acetate (Acetate ion),
Sodium acetate (Sodium acetate trihydrate)
[1] Sodium acetate (Sodium acetate, Sodium acetate hydrate, Sodium acetate trihydrate) 💬 --[2] 81, 251 💬
268Sodium acetate (1-13C)[2] Acetate (Acetate ion),
Sodium acetate (Sodium acetate trihydrate)
[1] Sodium acetate (Sodium acetate, Sodium acetate hydrate, Sodium acetate trihydrate) 💬 --[1] 251 💬
269Sodium-[o-[(2,6-dichlorophenyl)-amino]- phenyl]-acetate[1] Acetate (Acetate ion)---[1] 46 💬
270Sodium-[o-[(2,6-dichlorophenyl)-amino]-phenyl]-acetate[1] Acetate (Acetate ion)---[1] 46 💬
271Somatostatin analog (lanreotide or octreotide)
(Lanreotide acetate)
[3] Lanreotide (Lanreotide acetate),
Octreotide (Octreotide acetate),
Somatostatin (Somatostatin acetate)
[7] Octreotide ,
Octreotide acetate (Octreotide acetate),
Lanreotide acetate (Lanreotide acetate),
Octreotide pamoate ,
Octreotide acetate (Octreotide acetate),
Somatostatin ,
Octreotide hydrochloride 💬
[5] SSTR1,
SSTR2,
SSTR3,
SSTR4,
SSTR5 💬
[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
272Somatuline Autogel (lanreotide acetate)[2] Acetate (Acetate ion),
Lanreotide (Lanreotide acetate)
[1] Lanreotide acetate (Lanreotide acetate) 💬 [2] SSTR2,
SSTR5 💬
[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
273Somatuline Autogel® (lanreotide) 60, 90, 120 mg.
(Lanreotide acetate)
[1] Lanreotide (Lanreotide acetate)[1] Lanreotide acetate (Lanreotide acetate) 💬 [2] SSTR2,
SSTR5 💬
[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
274Sotrastaurin
(Sotrastaurin acetate)
[1] Sotrastaurin (Sotrastaurin acetate)[2] Sotrastaurin ,
Sotrastaurin acetate (Sotrastaurin acetate) 💬
[4] PRKCD,
PRKCE,
PRKCH,
PRKCQ 💬
[30] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Aldosterone synthesis and secretion, Apelin signaling pathway, Autophagy - animal, C-type lectin receptor signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemokine signaling pathway, Diabetic cardiomyopathy, Estrogen signaling pathway, Fc gamma R-mediated phagosome formation, GnRH signaling pathway, IgSF CAM signaling, Inflammatory mediator regulation of TRP channels, Insulin resistance, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Prion disease, Shigellosis, Sphingolipid signaling pathway, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 97 💬
275Sotrastaurin (INN) acetate[2] Acetate (Acetate ion),
Sotrastaurin (Sotrastaurin acetate)
[2] Sotrastaurin ,
Sotrastaurin acetate (Sotrastaurin acetate) 💬
[4] PRKCD,
PRKCE,
PRKCH,
PRKCQ 💬
[30] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Aldosterone synthesis and secretion, Apelin signaling pathway, Autophagy - animal, C-type lectin receptor signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemokine signaling pathway, Diabetic cardiomyopathy, Estrogen signaling pathway, Fc gamma R-mediated phagosome formation, GnRH signaling pathway, IgSF CAM signaling, Inflammatory mediator regulation of TRP channels, Insulin resistance, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Prion disease, Shigellosis, Sphingolipid signaling pathway, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 97 💬
276Symptomatic treatment (Converting Enzyme inhibitor, Angiotensin II, Anti-renin, Aldosterone antagonist diuretic, Beta blocker, Calcium inhibitor, statin)
(Angiotensin II acetate)
[3] Aldosterone,
Angiotensin II (Angiotensin II acetate),
Calcium
[4] Angiotensin II ,
Angiotensin II ,
Aldosterone ,
Angiotensin II acetate (Angiotensin II acetate) 💬
[3] AGTR1,
AGTR2,
NR3C2 💬
[18] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 222 💬
277TAK-475
(Lapaquistat acetate)
[1] TAK-475 (Lapaquistat Acetate)[1] Lapaquistat acetate (Lapaquistat acetate) 💬 [1] FDFT1 💬 [1] Steroid biosynthesis 💬[1] 79 💬
278Teriparatide
(Teriparatide acetate)
[1] Teriparatide (Teriparatide acetate)[3] Teriparatide acetate (Teriparatide acetate),
Teriparatide ,
Teriparatide acetate (Teriparatide acetate, Teriparatide acetate hydrate) 💬
[1] PTH1R 💬 [4] Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬[7] 46, 68, 70, 71, 172, 235, 274 💬
279Teriparatide (FORTEO)
(Teriparatide acetate)
[1] Teriparatide (Teriparatide acetate)[3] Teriparatide acetate (Teriparatide acetate),
Teriparatide ,
Teriparatide acetate (Teriparatide acetate, Teriparatide acetate hydrate) 💬
[1] PTH1R 💬 [4] Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬[1] 274 💬
280Teriparatide [rDNA origin] contains recombinant human parathyroid hormone (1-34)
(Teriparatide acetate)
[2] Parathyroid hormone,
Teriparatide (Teriparatide acetate)
[4] Teriparatide acetate (Teriparatide acetate),
Parathyroid hormone ,
Teriparatide ,
Teriparatide acetate (Teriparatide acetate, Teriparatide acetate hydrate) 💬
[2] PTH1R,
PTH2R 💬
[4] Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬[1] 70 💬
281Teriparatide conjugated to a multiarm polyethylene glycol carrier molecule through a cleava
(Teriparatide acetate)
[2] Polyethylene glycol,
Teriparatide (Teriparatide acetate)
[6] Teriparatide acetate (Teriparatide acetate),
Polyethylene glycol 3350 ,
Teriparatide ,
Macrogol 4000 ,
Macrogol 6000 ,
Teriparatide acetate (Teriparatide acetate, Teriparatide acetate hydrate) 💬
[1] PTH1R 💬 [4] Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬[1] 235 💬
282Teriparatide conjugated to a multiarm polyethylene glycol carrier molecule through a cleavable linker
(Teriparatide acetate)
[2] Polyethylene glycol,
Teriparatide (Teriparatide acetate)
[6] Teriparatide acetate (Teriparatide acetate),
Polyethylene glycol 3350 ,
Teriparatide ,
Macrogol 4000 ,
Macrogol 6000 ,
Teriparatide acetate (Teriparatide acetate, Teriparatide acetate hydrate) 💬
[1] PTH1R 💬 [4] Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬[1] 235 💬
283Teriparatide Pen Injector
(Teriparatide acetate)
[1] Teriparatide (Teriparatide acetate)[3] Teriparatide acetate (Teriparatide acetate),
Teriparatide ,
Teriparatide acetate (Teriparatide acetate, Teriparatide acetate hydrate) 💬
[1] PTH1R 💬 [4] Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬[1] 274 💬
284TERLIPRESSIN
(Terlipressin acetate)
[1] Terlipressin (Terlipressin acetate)[2] Terlipressin ,
Terlipressin acetate (Terlipressin acetate) 💬
[3] AVPR1A,
AVPR1B,
AVPR2 💬
[6] Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption 💬[1] 299 💬
285Terlipressin acetate[2] Acetate (Acetate ion),
Terlipressin (Terlipressin acetate)
[2] Terlipressin ,
Terlipressin acetate (Terlipressin acetate) 💬
[3] AVPR1A,
AVPR1B,
AVPR2 💬
[6] Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption 💬[1] 299 💬
286Tesamorelin
(Tesamorelin acetate)
[1] Tesamorelin (Tesamorelin acetate)[2] Tesamorelin ,
Tesamorelin acetate (Tesamorelin acetate) 💬
[1] GHRHR 💬 [3] Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction 💬[1] 265 💬
287Tesamorelin (Egrifta)
(Tesamorelin acetate)
[1] Tesamorelin (Tesamorelin acetate)[2] Tesamorelin ,
Tesamorelin acetate (Tesamorelin acetate) 💬
[1] GHRHR 💬 [3] Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction 💬[1] 265 💬
288TETRACOSACTIDE
(Tetracosactide acetate)
[1] Tetracosactide (Tetracosactide acetate)[2] Cosyntropin ,
Tetracosactide acetate (Tetracosactide acetate) 💬
[1] MC2R 💬 [6] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[4] 83, 113, 145, 222 💬
289Tetracosactide acetate[2] Acetate (Acetate ion),
Tetracosactide (Tetracosactide acetate)
[2] Cosyntropin ,
Tetracosactide acetate (Tetracosactide acetate) 💬
[1] MC2R 💬 [6] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[2] 83, 145 💬
290TETRACOSACTIDE ESACETATO
(Tetracosactide acetate)
[1] Tetracosactide (Tetracosactide acetate)[2] Cosyntropin ,
Tetracosactide acetate (Tetracosactide acetate) 💬
[1] MC2R 💬 [6] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 113 💬
291TETRACOSACTIDE HEXAACETATE
(Tetracosactide acetate)
[1] Tetracosactide (Tetracosactide acetate)[2] Cosyntropin ,
Tetracosactide acetate (Tetracosactide acetate) 💬
[1] MC2R 💬 [6] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 113 💬
292Tetracosactide hexacetaat
(Tetracosactide acetate)
[1] Tetracosactide (Tetracosactide acetate)[2] Cosyntropin ,
Tetracosactide acetate (Tetracosactide acetate) 💬
[1] MC2R 💬 [6] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 222 💬
293TOCOPHERYL ACETATE[1] Acetate (Acetate ion)---[1] 206 💬
294Triptorelin
(Triptorelin acetate)
[1] Triptorelin (Triptorelin acetate)[3] Triptorelin ,
Triptorelin pamoate ,
Triptorelin acetate (Triptorelin acetate) 💬
[1] GNRHR 💬 [3] GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬[2] 49, 76 💬
295Triptorelin (GnRH agonists)
(Triptorelin acetate)
[1] Triptorelin (Triptorelin acetate)[3] Triptorelin ,
Triptorelin pamoate ,
Triptorelin acetate (Triptorelin acetate) 💬
[1] GNRHR 💬 [3] GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬[1] 76 💬
296Triptorelin acetate (3.75mg)[2] Acetate (Acetate ion),
Triptorelin (Triptorelin acetate)
[3] Triptorelin ,
Triptorelin pamoate ,
Triptorelin acetate (Triptorelin acetate) 💬
[1] GNRHR 💬 [3] GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬[1] 76 💬
297Triptorelin embonate, Triptorelin pamoate
(Triptorelin acetate)
[1] Triptorelin (Triptorelin acetate)[3] Triptorelin ,
Triptorelin pamoate ,
Triptorelin acetate (Triptorelin acetate) 💬
[1] GNRHR 💬 [3] GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬[1] 76 💬
298Triptorelin pamoate
(Triptorelin acetate)
[1] Triptorelin (Triptorelin acetate)[3] Triptorelin ,
Triptorelin pamoate ,
Triptorelin acetate (Triptorelin acetate) 💬
[1] GNRHR 💬 [3] GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬[2] 49, 76 💬
299Triptorelin pamoate 15mg
(Triptorelin acetate)
[1] Triptorelin (Triptorelin acetate)[3] Triptorelin ,
Triptorelin pamoate ,
Triptorelin acetate (Triptorelin acetate) 💬
[1] GNRHR 💬 [3] GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬[1] 76 💬
300Triptorelin pamoate(15mg)
(Triptorelin acetate)
[1] Triptorelin (Triptorelin acetate)[3] Triptorelin ,
Triptorelin pamoate ,
Triptorelin acetate (Triptorelin acetate) 💬
[1] GNRHR 💬 [3] GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬[1] 76 💬
301Ulipristal
(Ulipristal acetate)
[1] Ulipristal (Ulipristal acetate)[2] Ulipristal ,
Ulipristal acetate (Ulipristal acetate) 💬
[1] PGR 💬 [5] Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬[1] 10 💬
302ULIPRISTAL ACETATE[2] Acetate (Acetate ion),
Ulipristal (Ulipristal acetate)
[2] Ulipristal ,
Ulipristal acetate (Ulipristal acetate) 💬
[1] PGR 💬 [5] Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬[1] 10 💬
303Ursodeoxycholic acid+Low Dose Glucocorticoid(Methylprednisolone)
(Methylprednisolone acetate)
[2] Methylprednisolone (Methylprednisolone acetate),
Ursodeoxycholic acid
[3] Methylprednisolone ,
Ursodiol ,
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[2] NR1H4,
NR3C1 💬
[2] Bile secretion, Neuroactive ligand-receptor interaction 💬[1] 93 💬
304Warm compress prior to injection of glatiramer acetate[2] Acetate (Acetate ion),
Glatiramer (Glatiramer acetate)
[1] Glatiramer acetate (Glatiramer acetate) 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬
[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
305Zinc acetate[3] Acetate (Acetate ion),
Zinc,
Zinc acetate (Zinc acetate anhydrous)
[1] Zinc acetate (Zinc acetate, Zinc acetate hydrate, Zinc acetate dihydrate) 💬 --[2] 171, 299 💬
306Zinc acetate (20mg/d)[3] Acetate (Acetate ion),
Zinc,
Zinc acetate (Zinc acetate anhydrous)
[1] Zinc acetate (Zinc acetate, Zinc acetate hydrate, Zinc acetate dihydrate) 💬 --[1] 299 💬
307ZINC ACETATE DIHYDRATE[2] Acetate (Acetate ion),
Zinc acetate (Zinc acetate anhydrous)
[1] Zinc acetate (Zinc acetate, Zinc acetate hydrate, Zinc acetate dihydrate) 💬 --[1] 171 💬
308Zuretinol Acetate[2] Acetate (Acetate ion),
Zuretinol acetate (Zuretinol acetate)
---[1] 90 💬